International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Global Immunotherapy Drugs Market Research Report 2023-2028:
According to the latest report by IMARC Group, titled " Immunotherapy Drugs Market by Type (Monoclonal Antibodies, Vaccines, Interferons Alpha and Be ta, Interleukins), Therapy Area (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseas es, and Others), End User (Hospitals, Clinics, and Others), and Region 2023-2028
," the global immunotherapy drugs market size reached US$ 195.4 Billion in 2022.
Immunotherapy drugs refer to specialized medications used for treating a range of conditions, including lymphoma, melanoma, sarcoma, and lung, bladder, kidney, and breast cancer. These drugs stimulate the body's natural defenses by targeting and activating specific immune cells, such as Tcells, triggering an immunological response that aids in generating antibodies that prevent the growth of cancer cells.
They also help fight against allergies and infections caused by bacteria and viruses. Some of the standard immunotherapy drugs available in the market include checkpoint inhibitors, monoclonal antibodies, and cancer vaccines. They provide long-lasting and sometimes permanent responses with fewer side effects than traditional chemotherapy and radiation treatments.
As a result, immunotherapy drugs are becoming widely accepted and popular across the globe. Request for a PDF sample of this report: https://www.imarcgroup.com/immunotherapy-drugs-market/requestsample
The widespread prevalence of cancer, tumor, and target diseases and the expanding geriatric population are primarily driving the global immunotherapy drugs market growth. Besides this, the rising incidences of genetic and lifestyle diseases due to the adoption of sedentary lifestyles and hectic schedules are supporting the market growth. Moreover, the shifting consumer preference for immunotherapy drugs that can be customized based on the patient's genetic profile and tailored to their individual needs to improve treatment outcomes is acting as another significant growth-inducing factor. Additionally, the enhancing popularity of antibodies and biosimilar drugs, the rise in the number of hospitals, pharmacies, and research laboratories, and extensive investments in research and development (R&D) activities to enhance the formulation of immunotherapy drugs are creating a favorable outlook for the market. Furthermore, the escalating focus on strategic collaborations and new product developments by key market players to expand their product portfolio and gain a competitive edge is contributing to the market growth. Other factors, such as rising healthcare expenditure, a growing number of clinical trials, easy availability of favorable reimbursement policies, and significant advancements in companion diagnostics, are presenting remunerative growth opportunities for the market.
Looking forward, the market value is projected to reach US$ 327.8 Billion by 2028, expanding at a CAGR of 8.9% during 2023-2028.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/immunotherapy-drugs-market
Key Market Segmentation
The research report includes the following segments:
Breakup by Type:
• Monoclonal Antibodies
• Vaccines
• Interferons Alpha and Beta
• Interleukins
Breakup by Therapy Area:
• Cancer
• Autoimmune and Inflammatory Diseases
• Infectious Diseases
• Others
Breakup by End User:
• Hospitals
• Clinics
• Others
Breakup by Region:
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
Competitive Landscape with Key Players:
• AstraZeneca plc
• Bayer AG
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche AG
• GSK plc
• Merck & Co. Inc
• Pfizer Inc
• Sanofi S.A
1. How has the global immunotherapy drugs market performed so far and how will it perform in the coming years?
2. What has been the impact of COVID-19 on the global immunotherapy drugs market?
3. What are the key regional markets?
4. What is the breakup of the market based on the type?
5. What is the breakup of the market based on the therapy area?
6. What is the breakup of the market based on the end user?
7. What are the various stages in the value chain of the industry?
8. What are the key driving factors and challenges in the industry?
9. What is the structure of the global immunotherapy drugs market and who are the key players?
10. What is the degree of competition in the industry?
Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/immunotherapy-drugs-market/toc
We are the trusted business partners to the world's leading corporates, governments, and institutions
We are the trusted business partners to the world's leading corporates, governments, and institutions
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
